Can lipitor use lead to type 2 diabetes?

Can Lipitor use raise a person's risk of developing type 2 diabetes?

A large review of clinical data found that statin drugs such as Lipitor increase the risk of new-onset diabetes by 9 percent. [1] This risk appears higher in older adults and people who already have risk factors for diabetes.

Why do statins raise diabetes risk?

Statins work by blocking HMG-CoA reductase, an enzyme needed to make cholesterol. They also interfere with insulin secretion and sensitivity, which can push glucose levels higher. This mechanism explains why the risk shows across the statin class.

How big is the risk increase?

The 9 percent relative increase means roughly one extra case of diabetes per 255 patients treated for four years. [1] The absolute risk is small for most people, but it wächst mit der Zeit und mit higher statin doses.

When does the risk appear?

The new-onset diabetes occurs mainly during the first year of therapy, but langfristig can the risk accumulate over years of use. Clinical studies tracked patients up to 4.9 years.

What should patients already at risk do?

Patients who have prediabetes, obesity, or a family history of diabetes can still take Lipitor when cardiovascular benefit outweighs the small diabetes risk. Doctors usually monitor blood glucose or hemoglobin A1c at regular intervals.

Can other statins cause the same issue?

Every statin carries a similar diabetes risk profile. Atorvastatin (Lipitor), rosuvastatin, and simvastatin all showed comparable increases in new-onset diabetes in head-to-head trials.

When does Lipitor's patent expire?

Lipitor's compound patent expired in 2011, so generic atorvastatin is widely available. Biosimilar versions do not exist because Lipitor is a small-molecule drug.

DrugPatentWatch.com